专题:Lipid metabolism and disorders

This cluster of papers focuses on the genetic, pharmacologic, and physiological aspects of lipid metabolism, particularly the role of ANGPTL3, lipoprotein lipase, and related proteins in regulating triglyceride levels and their implications for cardiovascular diseases such as familial chylomicronemia syndrome and atherosclerosis. It also explores the involvement of adipose tissue and metabolic syndrome in lipid regulation.
最新文献
Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial

article Full Text OpenAlex

Hypertriglyceridemia: updates from clinical trials of new agents and real-world registries

article Full Text OpenAlex

A randomized, placebo-controlled phase 3 study of plozasiran in patients with familial chylomicronemia syndrome: PALISADE - 1 year open label extension

article Full Text OpenAlex

Berberine reverses impaired adipose angiogenesis to promote beige adipogenesis by HIF-1α/PRDM16 signaling

article Full Text OpenAlex

Efficacy for LDL-C–lowering and safety of pemafibrate extended-release formulation in patients with statin-intolerant hypercholesterolemia: A phase 3 multicenter, randomized, double-blind, placebo-controlled, parallel-group trial

article Full Text OpenAlex

Hepatoprotective effects of tetrahydropalmatine against NAFLD through autophagy activation and lipid metabolic reprogramming via the AMPK–mTOR–Sirt1 axis

article Full Text OpenAlex

Angiopoietin-2 aggravates Alzheimer’s disease by promoting blood-brain barrier dysfunction and neuroinflammation

article Full Text OpenAlex

Tryptophan metabolic gatekeeping in epithelial repair: GPR35-KLF5 circuitry decodes mucosal damage signals for repair programming

article Full Text OpenAlex

Efficacy of phospholipid-bound omega-3 versus standard omega-3 in patients with hypertriglyceridemia: a randomized clinical trial

article Full Text OpenAlex

Context‐Dependent Roles of ANGPTL2 ‐Mediated Inflammaging in Tissue Homeostasis, Pathological Tissue Remodeling, and Longevity

article Full Text OpenAlex

近5年高被引文献
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021

review Full Text OpenAlex 1295 FWCI192.8034

Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits

review Full Text OpenAlex 474 FWCI67.9729

The crucial role and mechanism of insulin resistance in metabolic disease

review Full Text OpenAlex 465 FWCI72.6051

Epidemiology of metabolic dysfunction-associated steatotic liver disease

review Full Text OpenAlex 451 FWCI179.3486

KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS

article Full Text OpenAlex 345 FWCI166.1546

99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical

letter Full Text OpenAlex 330 FWCI72.1605

Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease

review Full Text OpenAlex 322 FWCI47.8502

Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation

article Full Text OpenAlex 294 FWCI51.7358

Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease

review Full Text OpenAlex 283 FWCI52.9488

Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis

review Full Text OpenAlex 283 FWCI61.8831